Cingulate Inc. CING
CING
Cingulate Inc. CINGW
Cingulate Inc. SABS
SAB Biotherapeutics, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CVKD
Cadrenal Therapeutics, Inc. Common Stock MNPR
Monopar Therapeutics Inc. UNCY
Unicycive Therapeutics, Inc. DRMA
Dermata Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. NRSN
NeuroSense Therapeutics Ltd.
Cingulate Inc. CINGW
Cingulate Inc. SABS
SAB Biotherapeutics, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CVKD
Cadrenal Therapeutics, Inc. Common Stock MNPR
Monopar Therapeutics Inc. UNCY
Unicycive Therapeutics, Inc. DRMA
Dermata Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. NRSN
NeuroSense Therapeutics Ltd.
Performance
| Periode | CING | CINGW | SABS | ANEB | CVKD | MNPR | UNCY | DRMA | RNAZ | NRSN |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 8.16 % | 25.75 % | 86.18 % | 137.90 % | -9.20 % | 151.71 % | -18.98 % | 413.61 % | 25.11 % | 12.26 % |
| YTD | -19.41 % | -17.13 % | -38.27 % | 46.84 % | -12.13 % | 295.23 % | -43.94 % | 198.56 % | -79.54 % | 3.48 % |
| 1Y | -8.87 % | -17.54 % | -7.29 % | 26.78 % | -6.07 % | 1 529.31 % | 14.73 % | 221.71 % | -96.86 % | 9.17 % |
| 3Y | -98.58 % | -74.85 % | -71.38 % | -16.55 % | -77.96 % | 870.39 % | -23.45 % | -97.27 % | -100.00 % | -32.77 % |
| 5Y | -99.62 % | -94.97 % | -97.74 % | -67.32 % | -77.96 % | 248.49 % | -91.12 % | -99.67 % | -100.00 % | -70.54 % |
| 10Y | -99.62 % | -94.97 % | -97.74 % | -67.32 % | -77.96 % | -33.72 % | -91.12 % | -99.67 % | -100.00 % | -70.54 % |
| Depuis le début | -99.62 % | -94.97 % | -97.74 % | -67.32 % | -77.96 % | -33.72 % | -91.12 % | -99.67 % | -100.00 % | -70.54 % |